Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients

NCT04802954 is registered in ClinicalTrials.gov with IHU Strasbourg as lead sponsor.

NCT NCT04802954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04802954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
Lead sponsor
IHU Strasbourg
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2021
Completion date
February 14, 2024
Enrollment
400 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, hepatocellular carcinoma